Gapping up
In reaction to strong earnings/guidance:
- FINL +8.6%, CAG +3.7%, ACN +1.5%.
Notable movers in crypto space:
- NETE +64.4%, NXTD +38.9%, SSC +4.3%, LFIN +4.3%.
Other news:
- AEZS +58.2% (received FDA approval of Macrilen for diagnosis of adult growth hormone deficiency),
- GNRT +31.8% (WSJ reporting Euronav (EURN) / Gener8 (GNRT) nearing merger deal),
- NQ +22.5% (Still Checking, Possibly a Rosenblatt comment),
- CLNT +18.4% (Enters into an exclusivity agreement with the shareholder of Shanghai HongChuan Culture Promulgation, regarding a potential acquisition by EC Advertising),
- TCON +16.7% (Enters into a licensing agreement for the development and commercialization of TRACON's proprietary endoglin antibody),
- HSGX +14.9% (Enters into an agreement w/ MEDINET for the development and commercialization of NeoCart for the Japanese market),
- PYDS +12.8% (continued strength),
- VERI +9.7% (Veritone acquires the advanced data analytics software and related intellectual property assets of Atigeo Corporation; terms not disclosed),
- VTVT +9.1% (Enters into licensing agreement with Hangzhou Zhongmei Huadong Pharmaceutical Co, will receive an $8 mln upfront payment),
- SPPI +6.1% (Comments on updated clinicaltrials.gov listing for Poziotinib in EGFR Exon 20 Mutant Advanced Non-Small Cell Lung Cancer),
- EURN +3.7% (WSJ reporting Euronav (EURN) / Gener8 (GNRT) nearing merger deal),
- VTGN +3.4% (ticking higher following Intracoastal Capital 9.99% passive stake disclosure),
- VOYA +2.5% (To divest substantially all of its Closed Block Variable Annuity segment and its individual fixed and fixed indexed annuity business),
- ACN +1.5% (Accenture and Roche enter exclusive multi-year agreement, updates business outlook for fiscal 2018),
- NOK +1.5% (Signs multi-year patent license agreement with Huawei).
Analyst comments:
- FBP +2.3% (Upgraded to Buy at Citigroup)
- DISCA +1.9% (Upgraded to Buy at BofA/Merrill)
- SAVE +1.5% (Upgraded to Buy at Deutsche Bank)
- COTY +1.1% (Upgraded to Outperform at RBC Capital)
- WFC +1.1% (Upgraded to Buy at Buckingham)